Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1982-12-16
1987-12-15
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 81, 424150, A61K 4904
Patent
active
047132353
ABSTRACT:
Mixtures of cyanoacrylate monomers and radiopaque additives stable to the monomer produce radiopaque compositions useful in surgical and other applications. The additives useful in the compositions are triiodophenol, tetraiodethylene, iodoform and mixtures thereof. When Iodoform is included in the compositions, at least an equal molar amount of triiodophenol should also be included. The compositions include between 0.5 and 11 mole percent iodine and preferably contain at least 4 mole percent iodine. Inhibitors such as SO.sub.2 and hydroquinone may also be included. The compositions are preferably compounded with cyanoacrylate monomers of greater than 98-percent purity.
REFERENCES:
patent: 3360124 (1967-12-01), Stonehill
patent: 4086266 (1978-04-01), Corey
patent: 4354454 (1982-11-01), Hoffman
Cromwell et al., AJR:132, May, 1979, pp. 799-801.
Neuwirth et al., (I), Am. J. Obstet. Gynecol., 10-1-77, pp. 348-349.
Neuwirth et al., (II), Am. J. Obstet. Gynecol., 4-1980, pp. 951-956.
Physicians Desk Reference for Radiology & Nuclear Medicine (PDR), 1978/79, pp. 74-85.
CRX Medical, Inc.
Schenkman Leonard
LandOfFree
Radiopaque cyanoacrylates does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiopaque cyanoacrylates, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopaque cyanoacrylates will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1219056